AIMC Topic: Bioprinting

Clear Filters Showing 1 to 10 of 35 articles

Biofabrication of 3D bioprinted and organ-on-chip blood-brain barrier models using hCMEC/D3 for intranasal delivery of central nervous system therapeutics.

Biofabrication
The BBB remains a major obstacle to effective treatment of CNS disorders by limiting the entry of most therapeutics into the brain. The hCMEC/D3 is widely used as anin vitromodel to study BBB structure, permeability, and drug transport. In parallel, ...

3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response.

Science advances
Advanced three-dimensional (3D) tissue models that recapitulate autoimmune disease progression can enable mechanistic studies and accelerate the development of targeted therapies with reduced reliance on systemic immunosuppression. Here, we present a...

AI-powered printability evaluation framework for 3D bioprinting using Hausdorff distance metrics.

Biofabrication
3D bioprinting enables rapid fabrication of complex biological structures for tissue engineering applications. However, optimizing bioink formulation remains challenging due to complex relationships among material properties, printability, and cell v...

Alginate-based 3D bioprinting strategies for structure-function integrated tissue regeneration.

Journal of materials chemistry. B
Alginate-based biomaterials have been widely used for tissue repair and regeneration, owing to their tunability, biocompatibility, biodegradability, and low cytotoxicity. With the rapid advancement of bioprinting technology, alginate has increasingly...

Programmable Biointerfaces and Adaptive Functionality in Next-Generation Green Nanomaterials.

ACS synthetic biology
Recent advances in green nanomaterials have primarily focused on mitigating toxicity through passive approaches, yet emerging technologies suggest a transformative paradigm shift toward programmable nanomaterials with dynamic biointerfaces. This Revi...

3D Bioprinting and Artificial Intelligence for Tumor Microenvironment Modeling: A Scoping Review of Models, Methods, and Integration Pathways.

Molecular pharmaceutics
Recent advances in cancer research emphasize the development of physiologically relevant models to better understand tumor behavior and therapeutic responses. The tumor microenvironment (TME) plays a pivotal role in tumor progression, metastasis, and...

Organoids as predictive platforms: advancing disease modeling, therapeutic innovation, and drug delivery systems.

Journal of controlled release : official journal of the Controlled Release Society
As three-dimensional (3D), physiologically relevant models, organoids are rapidly becoming revolutionary platforms in biomedical research. With their ability to recapitulate tissue architecture, disease heterogeneity, and patient-specific therapeutic...

Recent progress in multifunctional theranostic hydrogels: the cornerstone of next-generation wound care technologies.

Biomaterials science
Theranostic hydrogels represent a groundbreaking approach by integrating therapeutic and diagnostic capabilities within a single platform, enabling real-time monitoring of wounds and precise treatment applications. These advanced materials are engine...

Innovations in cancer treatment: evaluating drug resistance with lab-on-a-chip technologies.

International journal of pharmaceutics
Lab-on-a-chip (LoC) technologies have emerged as transformative tools in cancer research, particularly in evaluating drug resistance, which remains a significant barrier to effective treatment. These miniaturized platforms allow for the integration o...

Leveraging transfer learning for efficient bioprinting.

Biofabrication
Bioprinting is a promising family of processes combining 3D printing with life sciences, offering the potential to significantly advance various applications. Despite numerous research efforts aimed at enhancing process modeling, optimizing capabilit...